Conformational switching in designed peptides: the helix/sheet transition  by Cerpa, Robert et al.
Conformational switching in designed peptides: the helix/sheet
transition
Robert Cerpa1, Fred E Cohen1,2,3 and Irwin D Kuntz1,3
Background: The structure adopted by peptides and proteins depends not only
on the primary sequence, but also on conditions such as solvent polarity or
method of sample preparation. We examined the effect that solution conditions
have on the folded conformations of two peptides, one of which contains the
photoisomerizable amino acid p-phenylazo-L-phenylalanine.
Results: Spectroscopic studies indicate that these two peptides switch
between helical and b sheet conformations. The switch behavior is influenced by
solution conditions including pH, NaCl concentration, temperature, and peptide
concentration. The CD spectrum of the peptide containing p-phenylazo-L-
phenylalanine changes from a spectrum characteristic of a b sheet to one
characteristic of an a helix upon irradiation.
Conclusions: We hypothesize that the structural states of the peptides are a
monomeric a helix and an aggregated antiparallel b sheet. Conditions
encouraging aggregation tend to favor sheet; conditions discouraging
aggregation tend to favor helix. Consideration of such solution-dependent
conformational changes may affect de novo protein design and have a bearing
on certain biological processes.
Introduction
An important goal of protein science is understanding
the relationship of the amino acid sequence of a protein
to its secondary and tertiary structure. Many approaches
to predicting structure from sequence build upon the
underlying assumption that in a given environment, a
sequence will have a unique structure. Although it has
long been recognized that proteins and peptides exhibit
an equilibrium between folded and denatured states, it is
increasingly clear that many peptides can be driven to
alternative folded structures by changing the solution
conditions. Rosenheck and Doty [1] demonstrated the
ability of polylysine to adopt different secondary struc-
tures depending on the solution environment and
method of sample preparation. Kabsch and Sander [2]
showed that identical pentapeptide sequences are found
with different structures, depending on the protein
context in which they occurred. Cohen et al. [3] extended
this observation to hexapeptides and longer sequences,
and more recently, Johnson and co-workers [4,5] and
Mutter et al. [6,7] have explored the effects of various
solvent additives to induce peptides to switch between
structured states. Mutter et al. dubbed peptides display-
ing dramatic, solvent-dependent conformational changes
‘switch peptides’. Recently, attention has focused on the
possibility that conformationally sensitive sequences
may play a role in diseases such as Alzheimer’s dementia
[8] and prion diseases [9].
Switch peptides have also been created by perturbing the
chemical nature of sidechains [10]. An intriguing class of
peptides utilize photoisomerizable sidechains [11]. Incor-
poration of azobenzene, either as a sidechain in the amino
acid p-phenylazo-L-phenylalanine [12] or by direct cou-
pling of azobenzene derivatives to other sidechains, has
enabled development of several peptides displaying
‘photoswitch’ behavior [11]. These studies generally
relied on homopolymers of azobenzene-containing amino
acids. In this paper, we explore site-specific substitution
of an azobenzene amino acid in small peptides. To accom-
plish this goal, we synthesized Fmoc-phenylazophenylala-
nine for utilization in solid-phase peptide synthesis.
We report here on two peptides (Fig. 1). The first was
developed to model a helix behavior [13]. Residues with
strong helix-forming potential were used [14]. The
helical potential was enhanced by placing residues with
negatively charged sidechains towards the N terminus,
and residues with positively charged sidechains towards
the C terminus [15]. Residues were also aligned to create
i, i+4 spaced salt bridges in the helical state between glu-
tamate and lysine sidechains, and the salt bridges were
also aligned so as to interact favorably with the helix
dipole moment [16]. The overall amino acid content was
chosen with the need for high water solubility in mind
and for convenience in assigning the proton NMR spec-
trum of the peptide. Tyrosine was used for convenient
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measurement of peptide concentration by UV
absorbance.
Although these design principles successfully enabled for-
mation of an a helix [13], a second design was (inadver-
tently) built into the peptide that favored b sheet, not a
helix, formation. Figure 2 illustrates how the peptide
could form an amphiphilic b sheet, with stabilizing salt
bridges between adjacent strands. This is a familiar design
principle that has been exploited by other researchers
[17,18].
The second peptide incorporated p-phenylazo-L-pheny-
lalanine [12], replacing the phenol sidechain of tyrosine
with an azobenzene group as a sidechain at position 12 in
the peptide. The photoisomerizable sidechain of the
phenylazophenylalanine residue provides yet another vari-
able affecting the balance between a helix and b sheet. In
the trans state of azobenzene, which tends to be the most
stable conformation, the rings lie in a plane and the mole-
cule has a very small dipole moment. The cis state,
however, is non-planar and has a large dipole moment
[19]. Because of the helix-stabilizing interactions between
the tyrosine at position 12 and the histidine at position 16
in the parent peptide [13], the tyrosine was replaced with
phenylazophenylalanine in anticipation of a significant
perturbation upon photoisomerization of the sidechain.
Given the potential to form two extremely different
ordered structures, a helix and b sheet, we investigated
the effect that different conditions have on the structure
that the peptides adopt.
Results
pH titration
Circular dichroism (CD) spectra of the pH titration of
peptide I, at 100 mM peptide concentration, are shown in
Figure 3a; the mean residue ellipticity at 222 nm is plotted
versus pH in Figure 3b. The buffer solution contains
100 mM NaCl and 1 mM each of sodium citrate, phos-
phate, and borate. The peptide spectra are typical of par-
tially helical peptides, displaying two minima at
approximately 222 nm and 205–208 nm with an isosbestic
point at 203 nm. The helical signal increases slightly from
pH 2 to pH 4 and then drops rapidly from pH 4 to pH 5,
continuing to decrease smoothly as the pH increases.
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Figure 1
Sequences of peptides I and II. Z, p-phenylazo-L-phenylalanine.
acetyl-ETATKAELLAKYEATHK-amide
acetyl-ETATKAELLAKZEATHK-amide
Figure 2
Antiparallel b sheet structure proposed for aggregated form of peptide
(only two strands are shown for clarity). Uppercase and lowercase
letters denote residues on different strands.
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Figure 3
(a) CD spectra of peptide I, 100 mM peptide concentration: pH 2 (),
pH 4 (–––), pH 6 (-----), pH 8 (--s--). (b) Mean residue ellipticity
[u]222nm of peptide I CD spectra, from pH 2 to pH 8. Buffer is 100 mM
NaCl/1 mM Na citrate/1 mM Na phosphate/1 mM Na borate, 5°C.
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Increasing the peptide I concentration to 1.2 mM results
in much different behavior. The peptide displays helical
spectra at pH 2 (Fig. 4a) and pH 3 (not shown). At pH 5,
however, the spectrum is most suggestive of b sheet struc-
ture (a single minimum at 218 nm) and the peptide solu-
tion was cloudy (Fig. 4a). At higher pHs, the spectra have
a single minimum that is significantly red-shifted; the
position of the UV maximum is also red-shifted (Fig. 4b).
Large amounts of precipitate were visible above pH 5; dis-
tortions due to light scattering may be affecting the
spectra. Dropping the pH from 8 to 2 restored the a
helical spectrum and caused most of the precipitate to re-
dissolve (Fig. 4b).
CD at selected pH values for peptide II, at 300 mM
peptide concentration, also demonstrate a helical spectra
at low pH and conversion to b sheet at higher pH, as
shown in Figure 5. These spectra were taken in distilled
water, as peptide II structure is affected by NaCl concen-
tration (see below). The a→b transition in peptide II can
also be reversed by returning the solution to acidic pH.
Salt concentration effects
The conformation of peptide II is also affected by NaCl
concentration. Figure 6 shows the CD spectra of peptide
II in 10 mM sodium phosphate, with and without 100 mM
NaCl added, at 900 mM peptide concentration. In Figure
7, spectra taken at intermediate concentrations of salt are
displayed. The solutions were prepared in D2O; the pH*
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Figure 4
CD spectra of peptide I, 1.2 mM peptide concentration, 5°C. (a) pH 2
(), pH 5 (–––). (b) pH 6 (), pH 8 (–––), spectrum upon returning
pH to 2 (-----). Same buffer as Fig. 3.
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Figure 5
CD spectra of peptide II, 300 mM peptide concentration, in distilled
water. pH 2.5 (–––), pH 7.8 (-----), pH 5.5 (), at 14°C.
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Figure 6
CD spectra of peptide II with and without NaCl, 900 mM peptide
concentration, 10 mM Na phosphate buffer in D2O: with 100 mM NaCl
added, pH* 2.2 (); no salt added, pH* 2.0 (-----), 15°C.
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was 2. Increasing salt concentration causes a smooth
increase in the amount of b sheet character in the spec-
trum. In Figure 8, infrared (IR) spectra of peptide II with
and without salt present show a clear shift in the amide I′
band. The sample containing salt shows an amide I′
absorption peak at 1612 cm–1, a region assigned to low-fre-
quency b sheet. When no salt is present in the sample, the
amide I′ peak occurs at approximately 1650 cm–1, in the a
helix/random coil region.
Temperature effects
Heating a solution of peptide II (peptide concentration of
75 mM) in a buffer solution containing 100 mM NaCl
yields the temperature denaturation curves shown in
Figure 9. Even at 70°C, there is a significant dip in the CD
curve at 220 nm; this may be due to the intense UV transi-
tion of the azobenzene sidechain in this region, although
there may also be residual b-sheet structure. After cooling
the heated solution back to 5°C, the spectrum displays the
characteristics of an a helix. Over several months’ time,
the spectrum gradually changes back to the single-
minimum spectrum characteristic of b sheet.
Concentration effects
CD spectra of peptide II in 100 mM NaCl buffer solution
at different peptide concentrations are shown in Figure
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Figure 7
CD spectra of peptide II, 700 mM peptide concentration, 10 mM Na
phosphate buffer in D2O: with 25 mM NaCl, pH* 1.9 (); with 75 mM
NaCl, pH* 1.9 (-----), 15°C. (Buffer spectrum not subtracted from
sample spectra.)
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Figure 8
FTIR spectra of peptide II with and without NaCl, same samples as Fig.
6: 900 mM peptide concentration, 10 mM Na phosphate buffer in
D2O: with 100 mM NaCl added, pH* 2.2 (); no salt added, pH* 2.0
(-----), 15°C.
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Figure 9
CD spectra of peptide II at different temperatures, 75 mM peptide
concentration in 100 mM NaCl/1 mM Na borate, phosphate and
citrate buffer, pH 2.2. (a) At temperatures of 5°C (), 30°C (–––),
50°C (-----). (b) At temperatures of 50°C (), 70°C (-----), and after
cooling solution back to 5°C (–––). (Buffer spectrum not subtracted
from sample spectra.)
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10. At the two higher concentrations, 376 mM and 75 mM
peptide (at pH 2.3), the spectra have the single minimum
at 218 nm characteristic of b sheets. At the lowest concen-
tration, 7.5 mM peptide (pH 2.2), however, the spectrum
has the double-minima appearance of an a helix.
Photoisomerization effects
The CD spectra of 75 mM peptide II are shown before
and after irradiation with UV light in Figure 11. The
peptide displays a single-minimum curve characteristic of
b sheet prior to exposure to UV light. After the 1 h irradia-
tion, the CD spectrum of the peptide displays the double-
minima curve typical of helix. Storing the peptide solution
in the dark does not reverse the transition, even after
several weeks time, unlike the behavior described above
for peptide II after heating.
Nuclear magnetic resonance spectra
The fingerprint and amide regions of the NOESY spec-
trum of peptide I are shown in Figure 12. Resonance
assignments are shown in Table 1 and are referenced to
trimethylsilylpropionic acid. The spectrum is typical of
helical peptides, as seen in the summary of observed
NOEs in Figure 13, and is virtually identical to the spec-
trum found for a related peptide studied under similar
conditions [13]. Fingerprint and amide regions of peptide
II are shown in Figure 14, and residues with chemical
shifts displaced by more than 0.05 ppm from their coun-
terparts in peptide I are summarized in Table 2. (The
sidechains of the lysines and of Thr4 and Leu9 could not
be traced unambiguously in the NOESY spectrum
because of the low peptide concentration needed to
prevent aggregation.) Of the amino acids common to both
peptides I and II, only His16 resonances are displaced by
more than 0.1 ppm. As the sidechain of His16 is in an i,
i+4 arrangement to the azobenzene sidechain of Z12, a
change in the environment (and the chemical shifts) of the
histidine is expected from the tyrosine→phenylazopheny-
lalanine mutation. The spectrum of peptide II contains
fewer of the characteristic helical NOESY peaks expected,
as shown in Figure 15. However, the lack of any signifi-
cant difference between the chemical shifts of peptides I
and II, combined with the helical NOEs observed for
peptide II, indicates that peptide II is significantly helical
under the conditions studied.
Summary
Both peptides display more b sheet character at higher
peptide concentrations, higher NaCl concentrations, and
at pH values of 5 or higher. Heating or photoisomerization
of the azobenzene chain in peptide II disrupts the b sheet
character of the spectra.
Discussion
The dramatic changes in the spectra of the peptides under
different conditions strongly suggest that the peptides are
undergoing structural transitions. The conformational states
proposed for the peptides—an intermolecular b sheet and a
monomeric a helix—are discussed below. These conforma-
tions provide a straightforward and consistent rationale for
interpreting CD and IR experiments as a function of
peptide concentration, salt concentration, pH, and tempera-
ture, as well as the change in the CD spectrum observed
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Figure 10
CD spectra of peptide II at different peptide concentrations, in 100
mM NaCl/1 mM Na borate, phosphate and citrate buffer, 5°C. 376 mM
peptide concentration, pH 2.3 (); 75 mM peptide concentration, pH
2.3 (–––); 7.5 mM peptide concentration, pH 2.2 (-----). (Buffer
spectrum not subtracted from sample spectra.)
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Figure 11
CD spectra of peptide II before () and after (-----) UV irradiation. 75
µM peptide concentration, 100 mM NaCl/1 mM Na borate, phosphate
and citrate buffer, 5°C, pH 2.3. (Buffer spectrum not subtracted from
sample spectra.)
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upon UV irradiation of peptide II. We also consider experi-
mental artifacts that might complicate this interpretation.
We start by examining the hypothesis that the structural
states we observe are an intermolecular b sheet aggregate
(see Fig. 2) and a monomeric helix. The similar spectra and
characteristic helical NOEs observed in the NMR experi-
ments on peptides I and II (Figs 12–15), as well as in the
parent peptide studied earlier [13], clearly support an a
helical conformation at low pH and low salt conditions.
The CD experiments as a function of peptide concentra-
tion support the hypothesis that the b sheet state arises
due to aggregation: a helix is stable at lower concentration,
whereas the b sheet spectra are observed at higher concen-
trations where aggregation is more likely. A similar antipar-
allel b sheet aggregate structure has been proposed for an
amphiphilic peptide that forms a highly stable b sheet [20].
This model also accounts for the results observed in the
experiments in which pH is varied. The pH titration of
peptide I at 1.2 mM concentration suggests that the
peptide forms an a helix at pH 2, where the peptide
carries a net charge of +4 that would disfavor aggregation.
As the pH rises and the glutamic acid residues begin to
deprotonate, the a helical spectrum becomes distorted
(data not shown); at pH 5, where most of the glutamic
acid residues are negatively charged, the peptide carries
a net charge of +1 and has less electrostatic repulsion to
overcome to aggregate. This aggregation event occurs at
much lower concentration in peptide II than in peptide
I. At 100 mM peptide concentration and 100 mM NaCl
concentration, peptide I displays a (partially) helical con-
formation at all pH values. Peptide II, however, gives
rise to a b sheet CD spectrum at 75 mM peptide concen-
tration at pH 2.3, 100 mM NaCl concentration.
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Table 1
Resonance assignments of peptide I
Residue NH aH bH gH dH eH NeH Other
Acetyl 2.05
Glu1 8.47 4.38 2.00 2.50
2.11
Thr2 8.29 4.31 4.25 1.24
Ala3 8.43 4.43 1.43
Thr4 8.00 4.28 4.43 1.27
Lys5 8.51 4.07 1.86 1.45 1.71 2.99 7.59
1.57
Ala6 8.37 4.16 1.44
Glu7 8.05 4.17 2.13 2.54
2.23
Leu8 8.28 4.14 1.85 1.71 0.89
Leu9 8.13 4.29 1.71 1.62 0.89
0.94
Ala10 8.00 4.20 1.48
Lys11 8.00 4.17 1.89 1.39 1.68 2.98 7.59
Tyr12 8.18 4.32 3.15 7.05 6.65
3.22
Glu13 8.62 4.14 2.15 2.66
Ala14 7.99 4.24 1.51
Thr15 7.72 4.30 4.22 1.19
His16 7.99 4.64 2.79 8.43 7.18
3.20
Lys17 8.28 4.30 1.77 1.44 1.68 3.00 7.60
Amide 7.17
7.71
Table 2
Resonance assignments of peptide II (>0.05 ppm Dd from peptide I)
Residue NH aH bH gH dH eH NeH Other
Thr2 8.27 4.38 4.30 1.23
Z12 8.25 4.50 3.36 7.42 7.72 *
His16 8.05 4.54 2.76 8.34 7.04
3.06
Lys17 8.20 4.24 * * * * *
*Resonance that could not be unambiguously assigned due to overlap.
The aggregated b sheet/monomer a helix model also pro-
vides a straightforward explanation of the NaCl titration
results and heating experiment. Peptide II, like peptide I,
has a net charge of +4 at low pH. Increasing the amount of
Research Paper  Conformational switching in peptides Cerpa et al.    97
Figure 12
NMR spectrum of peptide I recorded at 500
MHz, pH 2.4, 15°C. (a) Fingerprint region of
NOESY spectrum. (H16Ha-K17NH and
K17Ha-NH, although not seen here, are
marked on the basis of their locations on the
other side of the diagonal.) (b) Amide region
of NOESY spectrum.
(a)
(b)
salt present in solution screens the charge on the peptide
more effectively, facilitating formation of the aggregated b
sheet as observed in Figures 6 and 7. Similarly, heating
the peptide II solution could lead to disaggregation of the
b sheet complex into extended monomers at higher tem-
peratures. Upon cooling, the peptide would adopt the pre-
ferred monomeric conformation of a helix.
The conformations of peptide I and peptide II are influ-
enced by a wide variety of solution conditions. The fact that
a single peptide can adopt two very different secondary
structures based on the solution environment carries impor-
tant implications for biological systems and for protein
design and engineering. Earlier work has shown that
peptide conformation is affected by solution additives such
as trifluoroethanol and sodium dodecyl sulfate [4,5,7,21]
and interface effects [22]. In the experiments presented
here, we show that peptide concentration, pH, and salt con-
centration also play a role in determining peptide structure.
From a biological perspective, the most significant of these
factors are the pH and salt concentration; physiological
systems often contain environments of different ionic
strength or pH separated by membranes, which may influ-
ence peptide and protein structures in those environments.
The salt concentrations used here are well within the limits
encountered in living systems (ca. 150 mM [23]). Under-
standing how and why peptides aggregate may have impor-
tant biological implications, as the conversion of an a helical
peptide or protein into an aggregated, insoluble b sheet
form may be a factor in the pathology observed in
Alzheimer’s dementia and prion diseases [8,9].
The photoswitch behavior of peptide II is of distinct
interest, as it enables the study of a conformational switch
triggered by the rapid trans→cis azobenzene photoisomer-
ization. Other peptides containing phenylazophenylala-
nine [12] or azobenzene [11] sidechains have been
studied; many of these peptides also display changes in
secondary structure upon irradiation. An important differ-
ence should be noted between the previous systems and
the peptide studied here which renders peptide II particu-
larly useful. The systems used in previous experiments
were typically high molecular weight polymers with a
large percentage of azobenzene incorporated into each
peptide chain. In contrast, peptide II is relatively short
and contains only one azobenzene residue, making it
much more feasible to study the peptide and to examine
the effects of replacing individual residues on the struc-
tural transition.
An important caveat that must be considered in any inter-
pretation of our results is the possibility that spectral arti-
facts, not true conformational transitions, account for the b
sheet and a helix spectra. Aromatic residues, such as tyro-
sine and tryptophan, are known to distort the CD spectra
of peptides and proteins, due to overlap of electronic tran-
sitions from the peptide bonds and the aromatic rings
[24,25]. The azobenzene sidechain has particularly strong
electronic transitions in the peptide bond region, which
requires caution in interpreting CD spectra. IR spec-
troscopy utilizes a different physical property of the
peptide bond than CD, making it unlikely that artifacts
will be mistaken for true conformational changes in both
types of spectra. The weak azobenzene stretching fre-
quency occurs outside of the amide I′ region, and is
unlikely to affect the results of the Fourier transform
infrared (FTIR) experiments [26]. The experiments with
the peptides at different concentrations also lend support
to the aggregate/monomer hypothesis. As the concentra-
tion of the peptides dramatically affects the spectrum
obtained, the CD spectra almost certainly arise from a true
aggregation event, not from artifacts due to the aromatic
sidechains. Finally, NMR provides yet another indepen-
dent physical method of determining conformation and
the strongest evidence for the helical state of the peptides.
Attempts at acquiring NMR spectra using the b sheet
forming conditions were unsuccessful due to extremely
broad linewidths (data not shown). Although this prevents
solution NMR structure determination under those condi-
tions, it also provides another piece of evidence that an
aggregation event is occurring during the structural transi-
tion.
Two interesting aspects of the CD spectra presented here
merit comment. The first aspect is the relative intensity of
the minima of helix and sheet in Figures 4–6 and 9–11.
The spectrum of an a helix tends to have a minimum
approximately twice as strong as a b sheet spectrum, as
observed in the pure component spectra for polylysine
[27]. The spectra of a helix and b sheet presented here
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Figure 13
Summary of observed short and medium range NOEs for peptide I.
Regions where overlap prevented observation of a NOE are indicated
by asterisks.
αN
NN
αN(i, i+3)
αN(i, i+4)
βN
αβ(i, i+3)
E-T-A-T-K-A-E-L-L-A-K-Y-E-A-T-H-K
* *
* * *
5 10 15
have roughly equal intensities at their minima. A reason-
able explanation for this phenomenon is that the b sheet
conformation places a larger percentage of the peptide
bond chromophores in ordered secondary structure than
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Figure 14
NMR spectrum of peptide II recorded at 600
MHz, pH 2.4, 15°C. (a) Fingerprint region of
NOESY spectrum. (b) Amide region of
NOESY spectrum.
(a)
(b)
the a helical conformation. It is also possible that the
azobenzene electronic transitions discussed above,
although not strong enough to distort the qualitative infor-
mation contained in the CD spectra, affect the magnitude
of the spectra associated with a helix and b sheet. A
second unusual aspect of the CD spectra is observed in
Figure 4b, where both the n→p* and p→p* transitions of
the b sheet spectra observed at pH 6 and 8 are red-shifted,
and the intensity of the p→p* transition of the sheet at
pH 8 is stronger than that of the same transition in the a
helix. Such a red shift and enhanced intensity have been
calculated for model polyvaline b sheet spectra [28] and
are attributed to the strong twist in the sheet caused by
the b-branched sidechains of valine. It is possible that the
presence of the three threonine residues are causing
similar phenomena to occur in our spectra. Other
researchers have also noted unusually high intensity for
the p→p* transition in b sheets, although the maxima
were blue-shifted [29].
The data presented here add to the diversity of confor-
mational behavior observed in peptides. Our peptide
design provides an excellent system for studying b
sheet/a helix conformational switching. Mutation of
residues can illuminate the dependence of the conforma-
tional switching behavior on specific amino acids. Exper-
iments with a variety of salts and solution additives can
yield thermodynamic data for the conformational switch
under different solution conditions. Finally, the photo-
switch behavior of peptide II can be utilized for studying
the kinetics of secondary structure interconversion.
Rapid spectroscopic techniques have been developed
that can detect such changes on nanosecond [30] and
picosecond [31,32] time scales; studies utilizing peptide
II in this area are underway.
Materials and methods
Peptide synthesis and purification
Peptides were synthesized on an Applied Biosystems, Inc. (ABI) Model
431A peptide synthesizer using Fmoc (9-fluorenylmethoxycarbonyl)
chemistry. Benzotriazolyl tetramethyluronium hexafluorophosphate
(HBTU)/hydroxybenzotriazole (HOBt) coupling reagents were used for
peptide I; dicyclohexylcarbodiimide/HOBt coupling reagents were used
for peptide II. Double coupling of standard Fmoc amino acid residues
was employed. Standard Fmoc amino acids were purchased from Milli-
pore; reagents were purchased from ABI and Aldrich, and solvents from
ABI or Baxter. The procedure of Goodman and Kossoy [12] was used
to synthesize p-phenylazo-L-phenylalanine, and the Fmoc derivative was
synthesized using fluorenylmethylsuccinimidyl carbonate (Aldrich) [33].
Millipore PAL Resin was used to generate C-terminal amide groups, and
the N terminus was acetylated. Peptide I was cleaved using 95% trifluo-
roacetic acid (TFA)/3% anisole/1% ethanedithiol/1% thioanisole. After
90 min, the solution was filtered, the volume reduced by evaporation,
and the peptide was precipitated by adding cold ether. The precipitate
was redissolved in distilled H2O and lyophilized. Peptide II was cleaved
with 80% TFA/8% anisole/4% ethanedithiol/4% thioanisole. As peptide
II tended to form an oil upon addition of ether to the TFA solution, the
cleavage solution was evaporated and the excess scavengers sepa-
rated from the colored peptide oil by pipette. The oil was then redis-
solved in distilled H2O and lyophilized.
The crude peptides were purified by reverse-phase HPLC on Vydac C-
18 semipreparative columns using a water/acetonitrile gradient con-
taining 0.1% TFA, monitoring elution at either 275 nm (peptide I) or
325 nm (peptide II). Peptide I was subjected to a second purification
on a Vydac C-4 semipreparative column using water/acetonitrile/TFA
solvents. The identity of the purified peptides was established by FAB
mass spectrometry (peptide I, MH+ 1945.3 calc., 1945.1 found;
peptide II, MH+ 2033.1 calc., 2033.3 found; the sodium adduct was
also observed in both cases). Peptide purity was assayed by HPLC on
a Vydac C-18 analytical column, with detection at 215 nm. Peptide I
was 94% pure; peptide II was 99% pure and consisted of an 8:1
mixture of trans:cis isomers of the phenylazophenylalanine sidechain
(the peak consisting of pure trans isomer was isomerized on passage
through the HPLC UV detector).
Circular dichroism
CD on peptide II was carried out on a Jasco J-500 spectrometer. Cylin-
drical, temperature-controlled cuvettes were used. CD on peptide I
was performed on a Jasco J-710 spectrometer; rectangular cells and a
Peltier temperature control unit were employed. A baseline spectrum
was subtracted from the sample spectrum unless noted otherwise. In
the spectra collected in rectangular cells, the region near 260 nm,
although flat, was often offset from zero even after baseline correction;
this region was set to zero by subtracting the average of the data from
256 nm to 260 nm. No smoothing was performed on the CD spectra.
Fourier transform infrared spectroscopy
FTIR spectra of peptide II were collected on a Perkin-Elmer System
2000 FTIR microscope. A 50 mm path cell with calcium fluoride
windows was used. The HPLC-purified peptide was lyophilized at least
twice out of 20 mM HCl solution to remove traces of TFA, then
lyophilized once from D2O solution. The dry deuterated peptide was
then taken up in D2O buffers immediately before acquiring spectra;
pH* of solutions was measured after acquiring spectra. Spectra of the
buffers were also acquired under identical conditions and subtracted
from the peptide spectra. Residual water signal was removed by linear
interpolation across the narrow-linewidth water peaks. The spectra
were smoothed and the amide I′ region was fitted to a flat baseline; no
self-deconvolution was used.
Ultraviolet irradiation
Peptide II solution (75 mM peptide) was placed in a glass cell and the
cell was placed in a Pyrex beaker containing water and ice (replenished
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Figure 15
Summary of observed short and medium range NOEs for peptide II.
Regions where overlap prevented observation of a NOE are indicated
by asterisks
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periodically) to prevent heating of the sample. The beaker was then
placed a few inches from a medium pressure Hanovia L679A 450 W
lamp (equipped with a Pyrex glass shield to remove short-wavelength
light) for 60 min. CD spectra were then acquired within 10 min after
ending irradiation.
Nuclear magnetic resonance spectroscopy
NOESY, COSY, and HOHAHA spectra of peptide I in 90% H2O/10%
D2O at 15°C, 5 mM peptide concentration, pH 2.4, were recorded on
a General Electric 500 MHz Omega system, using presaturation to
suppress the water signal. A NOESY spectrum of peptide II in
90% H2O/10% D2O was recorded on a Varian Unity 600 MHz spec-
trometer at 15°C, 460 mM peptide concentration, pH 2.4, using a
10 mm probe; symmetrically shifted pulses were used for water sup-
pression [34]. A mixing time of 150 ms was used for the NOESY
spectra. The spectra were processed using software developed at
UCSF by M Day and D Kneller (unpublished data).
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